Skip to main content

How Haptens Differ from Antigens and Become Immunogens?

The difference between antigens vs. haptens is one the most concerning issues for people who are not familiar with them. As a matter of fact, antigens and haptens are similar in many ways. They are both molecules triggering immune responses and acting as antigenic agents. And they both work as immunogens and bind to antibodies although haptens in a different manner.

 

What distinguishes an antigen mostly from a hapten is that antigens are complete molecules spontaneously triggering immune response whereas haptens are fragmentary small molecules that are unable to elicit immune responses unless they are conjugated to a larger molecule, known as a carrier.

 

What are Antigens?

Antigens, including proteins, peptides, and polysaccharides, are immunogen molecules that can trigger immune responses or naturally bind to immune components. An antigen may have one or more epitopes, which are the determinants of recognition and binding to antibodies. Based on the resource and the way of generation, antigens could be classified into exogenous antigens, endogenous antigens, autoantigens, and neoantigens.

 

What are haptens?

 

Haptens, on the contrary, are incomplete antigens with molecular weight less than 2-5 kDa and not immunogenic for the lack of epitopes. They are small molecules, such as toxins, drugs, and hormones that are not capable of invoking immune responses when injected directly into animals. These small molecules can only elicit immune responses when attached to carrier macromolecules that are immunogenic. A lot of allergic reactions are a result of haptens, such as penicillin, chemically reaction with proteins in the body after drug injection or ingestion.

 

How a Hapten Triggers an Immune Response?

 

The term hapten is derived from the Greek haptein, meaning “to fasten”. So, haptens need to tightly conjugate with additional carriers like proteins through covalent bonds and form hapten-carrier molecule complexes, which will make haptens immunogenic and result in the production of anti-hapten antibodies. The attractive point is that these anti-hapten antibodies can tell and bind to the same hapten upon a second exposure, even if the hapten is in the absence of the carrier molecule.

 

Scientists now can take advantage of the immuno-chemical properties of haptens, such as the chemical structure, composition, immunogenicity, and analogues, to design and synthesize small-molecule haptens, inducing powerful immune responses to produce antibodies that bind to haptens with high affinity.

 

Common Drugs As Haptens

 

Drugs, which can be haptens, usually are small molecules that attach to proteins in the blood, such as BSA (bovine serum albumin) and KLH (keyhole limpet hemocyanin). The immune response triggered by a hapten will eventually display as an immune reaction to the drug, leading to skin eruptions, anaphylactic shock, or even life-threatening syndromes.

 

Antibiotics and anesthetics are common pharmaceutical drugs that can be haptens.

 

Penicillins, known for their anti-bacterial properties, are a group of antibiotics with the beta-lactam mechanism of action. However, beta-lactamase enzymes' resistance to beta-lactam antibiotics will break down penicillins and lead to the production of benzylpenicilloyl derivatives that bind to other proteins, further eliciting immune responses. This is why your doctor asks about your allergic history to penicillins and cephalosporins. Severe immune responses, or adverse immune-mediated reactions to subsequent exposure to haptens, include urticaria, asthma, angioedema, and drug allergic reactions.

 

Haptens could also be synthetic substances, such as the organic compounds benzene arsonate, trinitrophenol, and halothane, as well as naturally occurring polysaccharides, such as lactose.

 

Conclusion

 

Haptens mainly differ antigens from the ability to induce an immune response. Haptens are incomplete small molecules that require additional conjugation with other molecules such as carrier proteins to be immunogens while antigens can elicit immune responses by themselves. And haptens become immunogens the next time they are exposed to anti-hapten antibodies.

Comments

Popular posts from this blog

Primary Antibody vs. Secondary Antibody, How to Choose?

  Antibodies (or immunoglobulins) are Y -shaped glycoproteins released by the immune system  to detect and bind to "foreign" substances , known as " antigens ", triggering a cascade of actions to destroy these foreign invaders. Scientists would develop different antibodies for research use, which basically can be classified into primary and secondary antibodies . However, how to choose the right type of antibodies for different immunoassays in experiment procedures, such as western blotting (WB), enzyme-linked immunosorbent assays (ELISA), and immunoprecipitation (IP), is one of the most common questions for green hands in the laboratory.   P rimary A ntibod y vs. Secondary Antibody   Antibodies could be categorized into two types based on the binding capability and experimental applications— primary   antibodies   and  secondary antibodies.   The main difference between these two types of antibodies is that primary antibody binds specifically to ...

Single-cell Genomics Study Elucidates Human Cytomegalovirus Infection

  I nfection of β-herpesvirus h uman cytomegalovirus (HCMV) could be life-threatening or cause life-long suffering in the majority of humans. Moreover, the viral vertical transmission during pregnancy leads to most congenital birth defects. However, treatment and prevention options currently available are extremely   limited.   Challenges  in Studying HCMV–host Cell Interactions   More than 235 kbp of double-stranded DNA (dsDNA)  in HCMV make s the largest known genome of human herpesviruses. Besides, HCMV is similar to other herpesviruses with complicated transcriptional architecture, including alternative transcription start sites, alternative splicing events, and polycistronic transcripts. The complex transcriptional architecture enables strict temporal control of gene expression and the possibility of generating multiple distinct proteins from a single genomic locus. The complexity is further increased by host cellular heterogeneity and differences in i...